Orthovisc 630-254
Orthovisc 630-254 is a synovial fluid supplementation medium (FDA Class III; FDA product code MOZ, Acid, Hyaluronic, Intraarticular) made by Anika Therapeutics, Inc., approved under FDA PMA P030019 on 4 Feb 2004 and listed in FDA GUDID since 15 Aug 2014 (UDI-DI 10886705023110), active as of 23 Oct 2026.
Active
PMA
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10886705023110 | Date15 Aug 2014 | StatusListed |
| United States | FDA PMAAPPR | NumberP030019 | Date4 Feb 2004 | StatusActive |
Official records
- AccessGUDID record 10886705023110
- FDA PMA database P030019
From the FDA record
- Device description
- 2 mL, 15 mg/mL High Molecular weight Hyaluronan
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Across registries
- FDA PMA P030019 decided 4 Feb 2004 Active
- FDA GUDID UDI-DI 10886705023110 listed 15 Aug 2014 Listed
Timeline
- Approved FDA PMA P030019
- Listed FDA GUDID 10886705023110
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- Orthovisc
- Generic name
- Synovial fluid supplementation medium
- Model / reference
- 630-254
- Primary DI / UDI-DI
- 10886705023110
- PMA number
- FDA product code
- MOZ
- GMDN term
- Synovial fluid supplementation medium
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).
- GenVisc 850 by Channel-Markers Medical, LLC
- Hymovis High Molecular Weight Viscoelastic Hyaluronan by Fidia Farmaceutici
- Hyalgan Acid, Hyaluronic, Intraarticular by Fidia Farmaceutici S.p.A.
- Euflexxa (1% Sodium Hyaluronate) by Ferring Pharmaceuticals, Inc.
- Durolane by BIOVENTUS LLC
- Gel-Syn Acid, Hyaluronic, Intraarticular by Ibsa Institut Biochimique SA
- SYNOJOYNT by Mesoblast
- TriVisc by Channel-Markers Medical, LLC
- Synvisc Hylan G-F 20 by Sanofi Genzyme Corp.
- TRILURON by Fidia Farmaceutici S.p.A.